OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MICR58

20 Microns Ltd

Specialty ChemicalsVerified

20 Microns maintains a conservative capital structure with a debt-to-equity ratio of 0.38, below the industry median of 0.55, and a current ratio of 1.71, indicating adequate short-term liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints despite its strong operating cash flow of INR 317.86 million. Profitability metrics show a return on equity (ROE) of 14.53% and return on assets (ROA) of 8.73%, both exceeding the industry medians of 10.2% and 6.8%, respectively, suggesting efficient capital utilization and strong operational performance. Gross margin of 38.6% and operating margin of 10.7% are in line with the cohort, but net margin of 6.8% is slightly below the median of 7.3%, indicating potential pressure from interest or tax expenses. The company's revenue is derived from a broad range of industrial minerals and specialty chemicals, with no disclosed segment or geographic concentration exceeding 30% of total revenue. This diversification reduces exposure to single-market volatility but limits visibility into high-growth areas. Outlook for FY2024 shows a 12.3% year-over-year revenue increase to INR 9.13 billion, with a 15.6% operating income growth to INR 974.2 million. The company is expected to maintain a stable capital expenditure of INR 766.8 million, primarily for plant and equipment upgrades. Analysts project a 12.3% revenue growth for FY2025, driven by increased demand in the construction and automotive sectors. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk, with no near-term pressure from share issuance. The company has not disclosed any material dilution sources in recent filings, and its diluted shares outstanding remain unchanged at 35.29 million. No significant regulatory or geopolitical risks are flagged in the current period, though exposure to raw material price volatility remains a concern. Recent filings and transcripts indicate no material changes in business strategy or capital structure. The company has not issued new shares in the past 12 months, and no material lawsuits or regulatory actions are disclosed in the latest 10-K equivalent.

30-day price · MICR+32.78 (+22.3%)
Low$129.61High$187.04Close$179.97As of12 May, 00:00 UTC
Profile
Company20 Microns Ltd
TickerMICR.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. 20 Microns Limited is an India-based company engaged in the manufacturing and sale of industrial micronized minerals and specialty chemicals, serving both local and international markets.

Classification. 20 Microns is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

20 Microns maintains a conservative capital structure with a debt-to-equity ratio of 0.38, below the industry median of 0.55, and a current ratio of 1.71, indicating adequate short-term liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints despite its strong operating cash flow of INR 317.86 million. Profitability metrics show a return on equity (ROE) of 14.53% and return on assets (ROA) of 8.73%, both exceeding the industry medians of 10.2% and 6.8%, respectively, suggesting efficient capital utilization and strong operational performance. Gross margin of 38.6% and operating margin of 10.7% are in line with the cohort, but net margin of 6.8% is slightly below the median of 7.3%, indicating potential pressure from interest or tax expenses. The company's revenue is derived from a broad range of industrial minerals and specialty chemicals, with no disclosed segment or geographic concentration exceeding 30% of total revenue. This diversification reduces exposure to single-market volatility but limits visibility into high-growth areas. Outlook for FY2024 shows a 12.3% year-over-year revenue increase to INR 9.13 billion, with a 15.6% operating income growth to INR 974.2 million. The company is expected to maintain a stable capital expenditure of INR 766.8 million, primarily for plant and equipment upgrades. Analysts project a 12.3% revenue growth for FY2025, driven by increased demand in the construction and automotive sectors. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk, with no near-term pressure from share issuance. The company has not disclosed any material dilution sources in recent filings, and its diluted shares outstanding remain unchanged at 35.29 million. No significant regulatory or geopolitical risks are flagged in the current period, though exposure to raw material price volatility remains a concern. Recent filings and transcripts indicate no material changes in business strategy or capital structure. The company has not issued new shares in the past 12 months, and no material lawsuits or regulatory actions are disclosed in the latest 10-K equivalent.
Key takeaways
  • 20 Microns maintains a conservative capital structure with a debt-to-equity ratio of 0.38, below the industry median.
  • ROE of 14.53% and ROA of 8.73% indicate strong profitability and efficient capital use.
  • Revenue is diversified across industrial minerals and specialty chemicals, with no single segment exceeding 30% of total revenue.
  • Outlook for FY2024 shows 12.3% revenue growth, driven by demand in construction and automotive sectors.
  • Liquidity risk is moderate due to negative net cash, but dilution risk is low with no near-term issuance pressure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$9.13B
Gross profit$3.53B
Operating income$974.2M
Net income$623.8M
R&D
SG&A
D&A
SBC
Operating cash flow$317.9M
CapEx-$766.8M
Free cash flow$40.6M
Total assets$7.15B
Total liabilities$2.85B
Total equity$4.29B
Cash & equivalents
Long-term debt$1.65B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.29B
Net cash-$1.65B
Current ratio1.7
Debt/Equity0.4
ROA8.7%
ROE14.5%
Cash conversion51.0%
CapEx/Revenue-8.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricMICRActivity
Op margin10.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.8%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin38.6%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity38.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual revenue7,774,929,000 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:58 UTC#36968f02
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 06:01 UTCJob: 91e3cfeb